Next Article in Journal
Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis
Previous Article in Journal
Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients
Previous Article in Special Issue
Incidence, Survival Analysis and Future Perspective of Primary Peritoneal Mesothelioma (PPM): A Population-Based Study from SEER Database
 
 
Review

Article Versions Notes

Cancers 2022, 14(4), 981; https://doi.org/10.3390/cancers14040981
Action Date Notes Link
article pdf uploaded. 15 February 2022 14:18 CET Version of Record https://www.mdpi.com/2072-6694/14/4/981/pdf-vor
article xml file uploaded 17 February 2022 11:04 CET Original file -
article xml uploaded. 17 February 2022 11:04 CET Update https://www.mdpi.com/2072-6694/14/4/981/xml
article pdf uploaded. 17 February 2022 11:04 CET Updated version of record https://www.mdpi.com/2072-6694/14/4/981/pdf
article html file updated 17 February 2022 11:06 CET Original file -
article html file updated 18 February 2022 10:12 CET Update -
article html file updated 31 July 2022 19:04 CEST Update https://www.mdpi.com/2072-6694/14/4/981/html
Back to TopTop